176 related articles for article (PubMed ID: 26386116)
1. Serotonin transporter is not required for the development of severe pulmonary hypertension in the Sugen hypoxia rat model.
de Raaf MA; Kroeze Y; Middelman A; de Man FS; de Jong H; Vonk-Noordegraaf A; de Korte C; Voelkel NF; Homberg J; Bogaard HJ
Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(10):L1164-73. PubMed ID: 26386116
[TBL] [Abstract][Full Text] [Related]
2. RP5063, a novel, multimodal, serotonin receptor modulator, prevents Sugen 5416-hypoxia-induced pulmonary arterial hypertension in rats.
Bhat L; Hawkinson J; Cantillon M; Reddy DG; Bhat SR; Laurent CE; Bouchard A; Biernat M; Salvail D
Eur J Pharmacol; 2017 Sep; 810():83-91. PubMed ID: 28576407
[TBL] [Abstract][Full Text] [Related]
3. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension.
White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR
Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701
[TBL] [Abstract][Full Text] [Related]
4. Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice.
Dempsie Y; Morecroft I; Welsh DJ; MacRitchie NA; Herold N; Loughlin L; Nilsen M; Peacock AJ; Harmar A; Bader M; MacLean MR
Circulation; 2008 Jun; 117(22):2928-37. PubMed ID: 18506000
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension.
Poble PB; Phan C; Quatremare T; Bordenave J; Thuillet R; Cumont A; Huertas A; Tu L; Dorfmüller P; Humbert M; Ghigna MR; Savale L; Guignabert C
FASEB J; 2019 Mar; 33(3):3670-3679. PubMed ID: 30481487
[TBL] [Abstract][Full Text] [Related]
6. Continuous fluoxetine administration prevents recurrence of pulmonary arterial hypertension and prolongs survival in rats.
Zhu SP; Mao ZF; Huang J; Wang JY
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):e1-5. PubMed ID: 19473340
[TBL] [Abstract][Full Text] [Related]
7. SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction.
de Raaf MA; Schalij I; Gomez-Arroyo J; Rol N; Happé C; de Man FS; Vonk-Noordegraaf A; Westerhof N; Voelkel NF; Bogaard HJ
Eur Respir J; 2014 Jul; 44(1):160-8. PubMed ID: 24791833
[TBL] [Abstract][Full Text] [Related]
8. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
9. Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension.
Dai Z; Zhu MM; Peng Y; Jin H; Machireddy N; Qian Z; Zhang X; Zhao YY
Am J Respir Crit Care Med; 2018 Sep; 198(6):788-802. PubMed ID: 29664678
[TBL] [Abstract][Full Text] [Related]
10. Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.
Christou H; Hudalla H; Michael Z; Filatava EJ; Li J; Zhu M; Possomato-Vieira JS; Dias-Junior C; Kourembanas S; Khalil RA
J Pharmacol Exp Ther; 2018 Feb; 364(2):258-274. PubMed ID: 29212831
[TBL] [Abstract][Full Text] [Related]
11. Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension.
Aiello RJ; Bourassa PA; Zhang Q; Dubins J; Goldberg DR; De Lombaert S; Humbert M; Guignabert C; Cavasin MA; McKinsey TA; Paralkar V
J Pharmacol Exp Ther; 2017 Feb; 360(2):267-279. PubMed ID: 27927914
[TBL] [Abstract][Full Text] [Related]
12. Antioxidants for the treatment of patients with severe angioproliferative pulmonary hypertension?
Voelkel NF; Bogaard HJ; Al Husseini A; Farkas L; Gomez-Arroyo J; Natarajan R
Antioxid Redox Signal; 2013 May; 18(14):1810-7. PubMed ID: 22870869
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
14. Increased eicosanoid levels in the Sugen/chronic hypoxia model of severe pulmonary hypertension.
Al-Husseini A; Wijesinghe DS; Farkas L; Kraskauskas D; Drake JI; Van Tassel B; Abbate A; Chalfant CE; Voelkel NF
PLoS One; 2015; 10(3):e0120157. PubMed ID: 25785937
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension.
Al-Husseini A; Kraskauskas D; Mezzaroma E; Nordio A; Farkas D; Drake JI; Abbate A; Felty Q; Voelkel NF
Pulm Circ; 2015 Mar; 5(1):101-16. PubMed ID: 25992275
[TBL] [Abstract][Full Text] [Related]
16. Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.
Born E; Lipskaia L; Breau M; Houssaini A; Beaulieu D; Marcos E; Pierre R; Do Cruzeiro M; Lefevre M; Derumeaux G; Bulavin DV; Delcroix M; Quarck R; Reen V; Gil J; Bernard D; Flaman JM; Adnot S; Abid S
Circulation; 2023 Feb; 147(8):650-666. PubMed ID: 36515093
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
Bueno-Beti C; Sassi Y; Hajjar RJ; Hadri L
Methods Mol Biol; 2018; 1816():233-241. PubMed ID: 29987824
[TBL] [Abstract][Full Text] [Related]
18. The Sugen 5416/Hypoxia Mouse Model of Pulmonary Arterial Hypertension.
Bueno-Beti C; Hadri L; Hajjar RJ; Sassi Y
Methods Mol Biol; 2018; 1816():243-252. PubMed ID: 29987825
[TBL] [Abstract][Full Text] [Related]
19. Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.
Frump AL; Goss KN; Vayl A; Albrecht M; Fisher A; Tursunova R; Fierst J; Whitson J; Cucci AR; Brown MB; Lahm T
Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L873-90. PubMed ID: 25713318
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats.
Al Husseini A; Bagnato G; Farkas L; Gomez-Arroyo J; Farkas D; Mizuno S; Kraskauskas D; Abbate A; Van Tassel B; Voelkel NF; Bogaard HJ
Eur Respir J; 2013 Jan; 41(1):104-14. PubMed ID: 22835607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
